Recombinant dengue virus antigen comprising the capsid protein leader sequence, full-length prM protein, and full-length E protein
US8715694B2 · kind B2 · utility
50Cited by
13References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 16, 2012 |
| Grant date | May 6, 2014 |
| Priority date | — |
| Expiry date | Apr 16, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides polypeptides and virus-like particles having, for example, an ability to induce an immune response to flaviviruses. The polypeptides can include C15, prM, and E polypeptide sequences.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.